FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynecology, and can be used for prediction of placental insufficiency in women with threatening early miscarriage and habitual miscarriage in the anamnesis. Method involves 5–12-week gestation in the blood serum of CD178+ monocytes. If its value is 30.3 % and less, placental insufficiency is predicted in the second half of pregnancy.
EFFECT: using the invention enables predicting the development of placental insufficiency in the second half of pregnancy with a high degree of accuracy – 98_1 % from early gestation.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF THREATENING LATE MISCARRIAGE IN WOMEN WITH MISCARRIAGE THREAT OF EARLY STAGES AND RECURRENT PREGNANCY LOSS IN PAST MEDICAL HISTORY | 2015 |
|
RU2592241C1 |
| METHOD FOR PREDICTING TERMINATION OF PREGNANCY IN WOMEN WITH A THREATENING MISCARRIAGE AND A HISTORY OF HABITUAL MISCARRIAGE | 2021 |
|
RU2751419C1 |
| METHOD FOR PREDICTING PREMATURE BIRTH IN WOMEN WITH THREATENED EARLY MISCARRIAGE AND RECURRENT MISCARRIAGE IN HISTORY | 2021 |
|
RU2755269C1 |
| METHOD FOR PREDICTION OF RECURRENT THREATENING MISCARRIAGE | 2015 |
|
RU2585244C1 |
| METHOD FOR PREDICTING REPRODUCTIVE LOSSES BEFORE 22 WEEKS OF PREGNANCY IN WOMENT WITH THREATENED MISCARRIAGE AND RECURRENT MISCARRIAGE IN HISTORY | 2020 |
|
RU2746033C1 |
| METHOD FOR PREDICTION OF REPRODUCTIVE LOSS IN THE FORM OF NON-DEVELOPING PREGNANCY AND SPONTANEOUS MISSION IN WOMEN WITH THREATING EARLY MISSION | 2022 |
|
RU2789255C1 |
| METHOD FOR PREDICTION OF DEVELOPING PLACENTAL INSUFFICIENCY IN THE SECOND HALF OF PREGNANCY | 2015 |
|
RU2600791C1 |
| METHOD FOR PREDICTION OF REPRODUCTIVE LOSS IN THE FORM OF NON-DEVELOPING PREGNANCY AND SPONTANEOUS MISCARRIAGE IN WOMEN WITH THREATING EARLY MISCARRIAGE | 2022 |
|
RU2789258C1 |
| METHOD OF PREDICTING EFFICIENCY OF TREATING MISCARRIAGES | 2010 |
|
RU2439571C1 |
| METHOD OF PREDICTING MISCARRIAGE BY ASSESSING VASCULAR ENDOTHELIAL GROWTH FACTOR AND PROSTAGLANDIN F2Α IN THE PERIPHERAL BLOOD OF PREGNANT WOMEN DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION IN THE FIRST TRIMESTER | 2023 |
|
RU2800311C1 |
